
Stock Details
CEO
Brian James McNamara
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full Time Employees
24.56K
Address
Building 5, Weybridge, KT13 0NY
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Top Competitors
Income Statement
Financials
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Haleon plc $9.69
$0
$249.61
$325
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results